Regulation of insulin secretion and blood glucose metabolism by adrenomedullin

Alfredo Martínez, Cyprian Weaver, José López, Sam J. Bhathena, Theodore H. Elsasser, Mae Jean Miller, Terry W. Moody, Edward J. Unsworth, Frank Cuttitta

Research output: Contribution to journalArticlepeer-review

187 Scopus citations


Adrenomedullin (AM), a recently discovered hypotensive peptide, is expressed in the endocrine pancreas of different species, as demonstrated by immunocytochemistry. Electron microscopic studies with double immunogold showed colocalization of AM and pancreatic polypeptide. A homogeneous expression of AM receptor was found throughout the islet using in situ hybridization. Six different insulin-producing cell lines have been analyzed by reverse transcription-PCR and showed expression of both AM and its receptor. Two experimental models have been used to study the effects of AM in pancreatic physiology. 1) Analysis of isolated rat islets shows that AM inhibits insulin secretion in a dose-dependent manner. The monoclonal antibody MoAb-G6, which neutralizes AM bioactivity, was able to increase insulin release 5-fold; this effect was reversed by the addition of synthetic AM. 2) Oral glucose tolerance tests showed that iv injection of AM reduces the levels of insulin in the bloodstream with a concomitant increase in circulating glucose. These studies implicate AM as a newly defined factor of the insulin regulatory system that could be involved in disorders such as diabetes and obesity.

Original languageEnglish (US)
Pages (from-to)2626-2632
Number of pages7
Issue number6
StatePublished - 1996


Dive into the research topics of 'Regulation of insulin secretion and blood glucose metabolism by adrenomedullin'. Together they form a unique fingerprint.

Cite this